It was a packed 1.5-day program of making new connections and gaining valuable insights from our outstanding lineup of speakers and panellists, setting these companies and their funded research projects up for success.
It’s all about accelerating development and commercialisation of promising drugs and medical devices into products that can benefit people living with cardiovascular disease and diabetes, their families, and community, and Australia’s health system.
MTPConnect’s TTRA Program has invested $12M to back these companies developing new medical devices and drugs:
The TTRA team of Lauren Kelly, Dr Erin McAllum, Dr Dharmica Mistry and Dr Elise Needham were pleased to welcome everyone on board, along with MTPConnect team members from around Australia including Dr Tracey Wilkinson, Andrew Bowskill, Jarrod Belcher, Dr Santhni Subramaniam and Lisa Dube.
We look forward to supporting the cohort’s progress over the next few years, and to future opportunities to bring everyone together for wrap around support activities.
